trending Market Intelligence /marketintelligence/en/news-insights/trending/a8srp2klcs8e8dzdsqnoba2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Admedus secures A$7.7M investment as part of recapitalization

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Admedus secures A$7.7M investment as part of recapitalization

Admedus Ltd. raised up to A$7.7 million from Star Bright Holding Ltd., a Hong Kong-based investor.

Star Bright subscribed for 42,599,866 Admedus shares, priced 10 cents each, for proceeds of $4.26 million, and for 26,289,636 shares, priced 13.03 cents each, for proceeds of $3.43 million.

The investment increases Star Bright's interest in Admedus to up to 19.99%. The investor can nominate up to four Admedus board members.

The placement with Star Bright plus a $5 million loan facility are part of Admedus' initiative to recapitalize and restabilize its financial position. The company added that it will remain in voluntary suspension until it releases more details regarding the recapitalization plan.

The companies also entered a memorandum of understanding for 60% of Admedus' vaccines business, for an initial investment of A$18 million.

Australia-based Admedus develops medical technologies and devices.